https://www.vistaar.ai/whitepaper/ 2024-07-03T11:59:12+00:00 https://www.vistaar.ai/whitepaper/otc-drugs-manufacturing-gmp-and-quality-management/ 2024-07-03T09:57:57+00:00 https://www.vistaar.ai/wp-content/uploads/2024/03/Whitepaper_OTC-Drugs-Manufacturing-GMP-and-Quality-Management.png https://www.vistaar.ai/whitepaper/uk-innovative-devices-access-pathway-idap-summary/ 2024-07-03T11:58:33+00:00 https://www.vistaar.ai/wp-content/uploads/2024/03/Whitepaper_UK-Innovative-Devices-Access-Pathway-IDAP-summary.jpg https://www.vistaar.ai/whitepaper/summary-of-fda-new-pms-guidance-under-section-522/ 2024-07-03T11:58:52+00:00 https://www.vistaar.ai/wp-content/uploads/2024/03/thubmail.jpg https://www.vistaar.ai/whitepaper/new-dietary-ingredient-notification-procedures-and-timeframes/ 2024-07-03T11:59:00+00:00 https://www.vistaar.ai/wp-content/uploads/2024/05/WP-New-Dietary-Ingredient-Notification-Procedures-and-Timeframes.png https://www.vistaar.ai/whitepaper/global-trends-and-updates-in-regulatory-affairs/ 2024-07-03T11:59:08+00:00 https://www.vistaar.ai/wp-content/uploads/2024/03/Whitepaper_Global-Trends-and-Updates-in-Regulatory-Affairs.png https://www.vistaar.ai/whitepaper/digital-transformation-and-emerging-technologies-in-consumer-healthcare/ 2024-07-03T11:59:12+00:00 https://www.vistaar.ai/wp-content/uploads/2024/03/WP_Digital-Transformation-and-Emerging-Technologies-in-Consumer-Healthcare.jpg